Your browser doesn't support javascript.
loading
The role of infiltrating lymphocytes in the neo-adjuvant treatment of women with HER2-positive breast cancer.
Eustace, A J; Madden, S F; Fay, J; Collins, D M; Kay, E W; Sheehan, K M; Furney, S; Moran, B; Fagan, A; Morris, P G; Teiserskiene, A; Hill, A D; Grogan, L; Walshe, J M; Breathnach, O; Power, C; Duke, D; Egan, K; Gallagher, W M; O'Donovan, N; Crown, J; Toomey, S; Hennessy, B T.
Afiliación
  • Eustace AJ; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland. alex.eustace@dcu.ie.
  • Madden SF; Data Science Centre, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Fay J; Department of Histopathology, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Collins DM; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
  • Kay EW; Department of Histopathology, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Sheehan KM; Department of Histopathology, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Furney S; Department of Surgery, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Moran B; Department of Physiology, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Fagan A; Conway Institute, University College Dublin, Dublin, Ireland.
  • Morris PG; Department of Surgery, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Teiserskiene A; Department of Medical Oncology, Beaumont Hospital, Dublin, Ireland.
  • Hill AD; Cancer Trials Ireland, Dublin, Ireland.
  • Grogan L; Department of Surgery, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Walshe JM; Department of Medical Oncology, Beaumont Hospital, Dublin, Ireland.
  • Breathnach O; Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland.
  • Power C; Department of Medical Oncology, Beaumont Hospital, Dublin, Ireland.
  • Duke D; Department of Surgery, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Egan K; Department of Radiology, Beaumont Hospital, Dublin, Ireland.
  • Gallagher WM; Cancer Clinical Trials and Research Unit, Beaumont Hospital, Dublin, Ireland.
  • O'Donovan N; Conway Institute, University College Dublin, Dublin, Ireland.
  • Crown J; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
  • Toomey S; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
  • Hennessy BT; Cancer Trials Ireland, Dublin, Ireland.
Breast Cancer Res Treat ; 187(3): 635-645, 2021 Jun.
Article en En | MEDLINE | ID: mdl-33983492
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Terapia Neoadyuvante Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Año: 2021 Tipo del documento: Article País de afiliación: Irlanda
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Terapia Neoadyuvante Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Año: 2021 Tipo del documento: Article País de afiliación: Irlanda